The document discusses how pharmaceutical companies can utilize social media for new product commercialization, both before and after launch, highlighting opportunities for customer research to better understand prescribing behaviors, promoting products to early adopters in the pre-launch phase, and managing the experience trial of new medications post-launch through social media engagement and influence. The role of social media is presented as a way to supplement traditional marketing approaches and engage physicians through peer-to-peer discussion of clinical problems and treatment options.